Last reviewed · How we verify
Delsym — Competitive Intelligence Brief
marketed
Antitussive (non-opioid)
Taste receptor type 2 member 46, Solute carrier family 22 member 1, Cytochrome P450 2D6
Neuroscience
Small molecule
Live · refreshed every 30 min
Target snapshot
Delsym (dextromethorphan) — Generic (originally Roche).
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Delsym TARGET | dextromethorphan | Generic (originally Roche) | marketed | Antitussive (non-opioid) | Taste receptor type 2 member 46, Solute carrier family 22 member 1, Cytochrome P450 2D6 | 1958-01-01 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Antitussive (non-opioid) class)
- Generic (originally Roche) · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Delsym CI watch — RSS
- Delsym CI watch — Atom
- Delsym CI watch — JSON
- Delsym alone — RSS
- Whole Antitussive (non-opioid) class — RSS
Cite this brief
Drug Landscape (2026). Delsym — Competitive Intelligence Brief. https://druglandscape.com/ci/dextromethorphan. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing